Purnima Sarkar, MD
Internal Medicine · Earle, ARNPI 1205899572
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,000 of the $21,252 with a category attached, or 98.8%. Beigene USA, Inc. accounts for 98.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $21,014 and has fallen 99.9% since, to $30 in 2025. Among internal medicine clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 22 payments — averaging $965.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Beigene USA, Inc.$21K
- Sunovion Pharmaceuticals Inc.$174
- Seqirus USA Inc$30
- Merck$17
- GSK$16
- AstraZeneca$14
What the payments were for
- Consulting fees$21,00099%
- Food & beverage$2521%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Beigene USA, Inc. | 2 | $21,000 |
| Sunovion Pharmaceuticals Inc. | 16 | $174 |
| Seqirus USA Inc | 1 | $30 |
| Merck | 1 | $17 |
| GSK | 1 | $16 |
| AstraZeneca | 1 | $14 |
How this compares
$21,252 in reported general payments places this provider in the 95th percentile of 614 internal medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 52 | $54,841 |
| JardianceEmpagliflozin | 55 | $45,499 |
| MounjaroTirzepatide | 39 | $43,888 |
| EliquisApixaban | 31 | $25,649 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $20,436 |
| GlyxambiEmpagliflozin/Linagliptin | 27 | $16,442 |
| JanuviaSitagliptin Phosphate | 24 | $16,214 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $13,033 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $12,500 |
| XareltoRivaroxaban | 19 | $12,374 |
| SymbicortBudesonide/Formoterol Fumarate | 41 | $10,060 |
| LinzessLinaclotide | 11 | $7,450 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 456 | $6,406 |
| Clonidine | 60 | $5,886 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 281 | $4,475 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $16 | $33,46850 claims |
| MerckJanuvia, Janumet | $17 | $28,71436 claims |
| AstraZenecaSymbicort | $14 | $10,06041 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 614 internal medicine providers in Arkansas.
Other internal medicine in Earle
- David PyleJonesboro$93K
- Aaron StrobelLittle Rock$32K
- Stuart BensonRogers$24K
- John NorwoodJonesboro$21K
- Ahmed AliConway$18K
- Jeremy DavisLittle Rock$17K
- Tyree SealsFort Smith$14K
- Atif KhanBatesville$14K
- Ritesh RampureLittle Rock$13K
- Milton RoachLittle Rock$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.